Praxis precision medicines to present at the 2023 jefferies healthcare conference

Boston, june 02, 2023 (globe newswire) -- praxis precision medicines, inc. (nasdaq: prax), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (cns) disorders characterized by neuronal excitation-inhibition imbalance, today announced that management will present at the 2023 jefferies healthcare conference on friday, june 9, 2023 at 8:00 a.m. et.
PRAX Ratings Summary
PRAX Quant Ranking